LABCORP HOLDINGS INC. vs RadNet, Inc., two Medical Diagnostics stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Labcorp carries 0.73 turns of debt against equity comfortably; RadNet carries 0.82 turns uncomfortably, the difference being what the leverage sits on: a national lab network earning a 10.8% operating margin against imaging centers running a small net loss. Both convert price into cash at healthy rates, 6.2% and 7.2%, RadNet's flattered by depreciation-heavy accounting. The market prices Labcorp at 24.1 times earnings; RadNet has no earnings to price against its $5B. Labcorp pays the only dividend. Two volume businesses in diagnostics infrastructure, one financing routine growth, the other financing survival-plus-expansion; the similar cash yields conceal very different sources.
Comparison updated 2026-07-10.
| Metric | LH | RDNT |
|---|---|---|
| Price | $271.48 | $60.71 |
| Market cap | $22.5B | $4.7B |
| Sector | Medical Diagnostics | Medical Diagnostics |
| Stage | Mature | Growth |
| Implied growth (priced in) | -1.3% | — |
| P/E | 24.1 | — |
| P/B | 2.58 | 3.46 |
| P/S | 1.59 | 2.18 |
| EV/EBITDA | 17.3 | 23.8 |
| Revenue growth | +7.4% | +14.7% |
| Gross margin | 28.7% | — |
| Operating margin | 10.8% | -4.2% |
| Net margin | 6.7% | -0.7% |
| Return on equity | 10.8% | -1.1% |
| Return on assets | 4.9% | -0.4% |
| Return on invested capital | 7.5% | 2.0% |
| FCF yield | 6.2% | 7.2% |
| Dividend yield | 1.1% | — |
| Debt / equity | 0.73 | 0.82 |
| Current ratio | 1.73 | 1.17 |
| Altman Z (solvency) | 2.88 | 1.63 |
| Piotroski F (quality) | 4 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.